Chris Froome has rejected a report he will agree to a six-month "Acceptance of Consequences" ban following an adverse drugs test returned during the Vuelta a Espana.
The four-time Tour de France winner remains under scrutiny after elevated levels of the asthma medication salbutamol were discovered in a urine sample provided during his successful Vuelta campaign.
A report in Corriere della Sera on Tuesday suggested the Kenya-born Briton would accept the sanction on the advice of his wife and manager, Michelle, adding that Froome would seek a compromise with cycling's governing body the UCI by pleading negligence.
However, Froome posted on Twitter: "I have seen the report in Corriere della Serra this morning – it's completely untrue."
World Anti-Doping Agency (WADA) rules permit the use of salbutamol without the need for a therapeutic use exemption when inhaled up to a limit of 1,600 micrograms over 24 hours.
Froome's sample displayed a concentration of the substance that was double the WADA threshold of 1,000 nanograms per millilitre (ng/ml).
Froome has maintained he has not broken any rules and Team Sky's general manager David Brailsford said he is confident the rider stayed "within the permissible dose".
The adverse finding does not necessarily constitute a breach of the rules and the 32-year-old has not been hit with a provisional suspension.